Provigil
Modafinil is a wakefulness-promoting agent FDA-approved for narcolepsy, obstructive sleep apnea, and shift work sleep disorder (marketed as Provigil). Unlike traditional stimulants such as amphetamine and methylphenidate, modafinil has a distinct mechanism of action with lower abuse potential, making it a Schedule IV controlled substance rather than Schedule II. It has become one of the most widely used cognitive enhancers and 'smart drugs' in biohacking communities.
Take in the morning with or without food. Half-life is 12-15 hours - do not take after noon to avoid insomnia. Start with 100mg to assess tolerance before increasing to 200mg.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
Modafinil's primary mechanism involves inhibition of the dopamine transporter (DAT), increasing extracellular dopamine in the prefrontal cortex, nucleus accumbens, and other regions. Unlike amphetamines, it does not promote dopamine release or significantly affect norepinephrine or serotonin transporters at therapeutic doses, which contributes to its lower abuse potential.
Secondary mechanisms include activation of the orexin/hypocretin system (critical wakefulness neurons in the lateral hypothalamus), increased histamine release in the tuberomammillary nucleus (promoting arousal), inhibition of GABAergic neurons in the ventrolateral preoptic area (sleep-promoting region), and enhancement of glutamatergic transmission. This multi-target profile produces wakefulness without the jitteriness or peripheral sympathetic activation of traditional stimulants.
Modafinil also upregulates cortical serotonin, glutamate, and norepinephrine while reducing GABA levels, creating a net pro-cognitive, pro-alertness neurochemical state. The cognitive enhancement effects are most pronounced for executive function, working memory, and sustained attention tasks.
Hours 1-3: Onset of wakefulness and focus. Peak plasma concentration at 2-4 hours.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
Evidence boundary from the checked abstract: Intoxication and dependence associated to modafinil are uncommon.
Intoxication and dependence associated to modafinil are uncommon.
Evidence scope. This entry supports only the exact statement quoted from the live abstract; it does not independently verify OnePin's displayed dose, route, frequency, formulation, population, or broader mechanism.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 100mg; Oral; 1x daily (morning). No checked live PubMed abstract verified this exact displayed dose, route, and frequency for the same molecule/formulation and relevant population.
Primary safety claim: Headache (most common, 34% in clinical trials - often resolves with hydration). No checked live PubMed abstract directly verified this source-JSON safety claim at the displayed formulation, route, and regimen.
Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.
Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.
(modafinil), ~15 hours (armodafinil R-enantiomer)
Oral
Complete elimination
Oral (not significantly affected by food, though Tmax is delayed ~1 hour)
Of wakefulness promotion from a single 200mg dose
Hepatic (CYP3A4 primary, with amide hydrolysis). ~90% excreted in urine as metabolites. Modafinil is a CYP3A4 inducer and CYP2C19 inhibitor.
Storage. Store at controlled room temperature (20-25C). Protect from moisture. No special storage requirements.
Schedule IV controlled substance (DEA). FDA-approved for narcolepsy, shift work disorder, and obstructive sleep apnea. Off-label use for ADHD, cognitive enhancement, and fatigue. Prescription required in the US. Available OTC in some countries (India, Mexico). Generic versions widely available since 2012.
Put it to work
Open Modafinil straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Modafinil in the app →Go deeper
The complete Modafinil walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.